(Credit: Upsher-Smith Laboratories, LLC)
Upsher-Smith Laboratories, LLC has launched Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP, 2.5 mg/0.025 mg.
The product is an AA-rated generic version of the branded product, Lomotil* (diphenoxylate hydrochloride and atropine sulfate tablets), a combination prescription drug used to treat the symptoms of acute or chronic diarrhea.
The diphenoxylate hydrochloride and atropine sulfate tablet market had U.S. sales of approximately $64 million for the 12 months ending May, 2018 according to IQVIA.
|
Product |
Strength |
NDC # |
Package Size |
|
Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP |
2.5 mg/0.025 mg |
0832-0590-11 |
Bottle of 100 |
|
0832-0590-10 |
Bottle of 1,000 |
Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP are classified as a Schedule V controlled substance.
* Lomotil is a registered trademark of G.D. Searle LLC
(Source: Upsher-Smith Laboratories, LLC)
